Jasper Therapeutics(JSPR)
$11.77-1.91 (-13.96%)
JSPR
Jasper Therapeutics earnings date
$11.77
At close:-1.91 (-13.96%)
Want to see JSPR full AI Analyst Report?
Jasper Therapeutics (JSPR) Q1 2024 Earnings Report
1,073 Followers
JSPR Q1 2024 EPS Results
- Actual EPS
- -$30.90
- Consensus EPS
- -$36.75
- Beat/Miss
- Beat by +$5.85
- One Year Ago EPS
- -$48.00
JSPR Q1 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/14/2024
- Time
- Before Open
- Conference Call
- Tuesday, May 14, 2024
JSPR Upcoming Earnings
Jasper Therapeutics's next earnings date is estimated for March 9, 2027, based on past reporting schedules.
Q1 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JSPR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 09, 2027 | 2026 (Q4) | -8.11- | -9.6 | ― | ― |
| Nov 16, 2026 | 2026 (Q3) | -1.77-10.19 | -33.9 | 69.94% (+23.71) | |
| Aug 14, 2026 | 2026 (Q2) | -8.04-3.00 | -52.2 | 94.25% (+49.20) | |
| May 14, 2026 | 2026 (Q1) | -14.57-1.20 | -42.3 | 97.16% (+41.10) | |
| Mar 30, 2026 | 2025 (Q4) | -23.89-9.60 | -48.6 | 80.25% (+39.00) | |
| Nov 10, 2025 | 2025 (Q3) | -36.45-33.90 | -37.2 | 8.87% (+3.30) | |
| Aug 13, 2025 | 2025 (Q2) | -39.79-52.20 | -29.1 | -79.38% (-23.10) | |
| May 12, 2025 | 2025 (Q1) | -40.43-42.30 | -30.9 | -36.89% (-11.40) | |
| Feb 27, 2025 | 2024 (Q4) | -37.63-48.60 | -45 | -8.00% (-3.60) | |
| Nov 07, 2024 | 2024 (Q3) | -32.14-37.20 | -48 | 22.50% (+10.80) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

